Genotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from Peru.

SETTING Twenty-nine epidemiological unrelated and mostly multidrug-resistant Mycobacterium tuberculosis (MDR-TB) strains from Peruvian patients. OBJECTIVE To investigate the molecular genetics of MDR-TB strains recovered in a Latin American country. DESIGN Antimicrobial agent susceptibility testing, major genetic group designation, IS6110 fingerprinting, spoligotyping, and automated deoxyribonucleic acid sequencing of regions of the katG, rpoB, embB, gyrA, and pncA genes with mutations commonly associated with drug resistance. RESULTS Nineteen isolates were found to be multidrug-resistant by susceptibility testing. IS6110 typing showed that virtually all isolates were unique and therefore had independently acquired drug resistance. Seventy-nine percent of isoniazid-resistant strains had a Ser315Thr amino acid change in KatG. Ninety-five percent of rifampin-resistant isolates had amino acid replacements in the rifampin-resistance determining region of RpoB. Six of 11 ethambutol-resistant strains had EmbB alterations. Eleven pyrazinamide-resistant strains had distinct mutations in pncA. CONCLUSION Virtually all organisms evolved drug resistance independently. The types of drug resistance-associated mutations identified were very similar to changes occurring in isolates from other areas of the world. Nucleotide sequence-based strategies for rapid detection of drug resistance-conferring mutants will be applicable to organisms recovered in Peru, and potentially other areas of Latin America.

[1]  J. T. Crawford,et al.  A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes. , 1996, JAMA.

[2]  J. T. Crawford,et al.  Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology , 1993, Journal of clinical microbiology.

[3]  D van Soolingen,et al.  Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. , 1996, The Journal of infectious diseases.

[4]  M. Raviglione,et al.  Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  C. Woodley,et al.  Transmission of a highly drug-resistant strain (strain W1) of Mycobacterium tuberculosis. Community outbreak and nosocomial transmission via a contaminated bronchoscope. , 1997, JAMA.

[6]  J. Musser,et al.  Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms , 1997, Antimicrobial agents and chemotherapy.

[7]  D. van Soolingen,et al.  Analysis of the population structure of Mycobacterium tuberculosis in Ethiopia, Tunisia, and The Netherlands: usefulness of DNA typing for global tuberculosis epidemiology. , 1995, The Journal of infectious diseases.

[8]  A. Telenti,et al.  Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations , 1997, Antimicrobial agents and chemotherapy.

[9]  V. Ritacco,et al.  Nosocomial spread of human immunodeficiency virus-related multidrug-resistant tuberculosis in Buenos Aires. , 1997, The Journal of infectious diseases.

[10]  F. Baquero,et al.  Genetic characterization of multidrug-resistant Mycobacterium bovis strains from a hospital outbreak involving human immunodeficiency virus-positive patients , 1997 .

[11]  C. Inderlied,et al.  Detection of rifampin resistance in Mycobacterium tuberculosis by use of a rapid, simple, and specific RNA/RNA mismatch assay. , 1997, The Journal of infectious diseases.

[12]  P. Small,et al.  The transcontinental transmission of tuberculosis: A molecular epidemiological assessment. , 1996, American journal of public health.

[13]  A. Telenti,et al.  Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level , 1997, Journal of clinical microbiology.

[14]  L. Wayne,et al.  Simple pyrazinamidase and urease tests for routine identification of mycobacteria. , 1974, The American review of respiratory disease.

[15]  Ying Zhang,et al.  Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus , 1996, Nature Medicine.

[16]  P. de Rijk,et al.  Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampin , 1997, Antimicrobial agents and chemotherapy.

[17]  J T Douglas,et al.  Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia , 1995, Journal of clinical microbiology.

[18]  A. Telenti,et al.  Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations , 1994, Antimicrobial Agents and Chemotherapy.

[19]  A. Telenti,et al.  Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis , 1993, The Lancet.

[20]  J. Musser,et al.  Antimicrobial agent resistance in mycobacteria: molecular genetic insights , 1995, Clinical microbiology reviews.

[21]  J. Musser,et al.  Characterization of the phylogenetic distribution and chromosomal insertion sites of five IS6110 elements in Mycobacterium tuberculosis: non-random integration in the dnaA-dnaN region. , 1998, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[22]  I. H. Lim,et al.  Lack of clinical significance for the common arginine-to-leucine substitution at codon 463 of the katG gene in isoniazid-resistant Mycobacterium tuberculosis in Singapore. , 1997, The Journal of infectious diseases.

[23]  T. Whittam,et al.  Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[24]  L. Benson,et al.  Recombinant Mycobacterium tuberculosis KatG(S315T) is a competent catalase-peroxidase with reduced activity toward isoniazid. , 1997, The Journal of infectious diseases.

[25]  Y. Kazumi,et al.  Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis. , 1997, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[26]  D. Young,et al.  Differentiation of Mycobacterium tuberculosis isolates by spoligotyping and IS6110 restriction fragment length polymorphism , 1997, Journal of clinical microbiology.

[27]  J. Musser,et al.  Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. , 1998, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[28]  M. Felten,et al.  Drug-resistant tuberculosis: laboratory issues. World Health Organization recommendations. , 1994, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[29]  F. Portaels,et al.  Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay. , 1995, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[30]  K. Feldmann,et al.  Disequilibria in the distribution of rpoB alleles in rifampicin-resistant M. tuberculosis isolates from Germany and Sierra Leone. , 1997, Microbial drug resistance.

[31]  A. Telenti,et al.  Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing. , 1995, Archives of pathology & laboratory medicine.

[32]  P. Groenen,et al.  Nature of DNA polymorphism in the direct repeat cluster of Mycobacterium tuberculosis; application for strain differentiation by a novel typing method , 1993, Molecular microbiology.

[33]  J. Musser,et al.  Routine rapid Mycobacterium species assignment based on species-specific allelic variation in the 65-kilodalton heat shock protein gene (hsp65). , 1997, Archives of pathology & laboratory medicine.

[34]  A. Telenti,et al.  The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol , 1997, Nature Medicine.

[35]  A. Khomenko,et al.  Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. , 1969, Bulletin of the World Health Organization.

[36]  J. T. Crawford,et al.  An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. , 1992, The New England journal of medicine.

[37]  J. Bates,et al.  Diversity of DNA Fingerprints ofMycobacterium tuberculosis Isolates in the United States , 1998, Journal of Clinical Microbiology.

[38]  R. Gilman,et al.  Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis , 1997, Antimicrobial agents and chemotherapy.

[39]  H L Rieder,et al.  Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. , 1998, The New England journal of medicine.

[40]  J. T. Crawford,et al.  Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. , 1996, JAMA.